ask="6.50"
ask_size="500"
average_daily_volume="968531"
bid="5.89"
bid_size="500"
book_value="0.05"
change="+0.33"
change_from_200_day_moving_average="1.43"
change_from_50_day_moving_average="0.07"
change_from_52_week_high="-1.44"
change_From_52_week_low="4.62"
change_in_percent="+5.57%"
close="6.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42598000"
high="6.27"
high_52_weeks="7.69"
last_trade_date="1/24/2017"
last_trade_price="6.25"
last_trade_size="41020"
last_trade_time="4:00pm"
low="5.89"
low_52_weeks="1.63"
market_capitalization="460.99M"
moving_average_200_day="4.82"
moving_average_50_day="6.18"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="5.95"
pe_ratio="N/A"
peg_ratio="-0.32"
percent_change_from_200_day_moving_average="+29.80%"
percent_change_from_50_day_moving_average="+1.08%"
percent_change_from_52_week_high="-18.73%"
percent_change_from_52_week_low="+283.44%"
previous_close="5.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="109.63"
price_per_sales="19.87"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.02"
stock_exchange="NMS"
symbol="BCRX"
volume="865256"
weeks_range_52="1.63 - 7.69"
